» Authors » Alexander Gavralidis

Alexander Gavralidis

Explore the profile of Alexander Gavralidis including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 10
Citations 130
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Kelly M, Mohammed A, Okin D, Alba G, Jesudasen S, Flanagan S, et al.
Crit Care Explor . 2023 Jun; 5(6):e0927. PMID: 37332365
Objectives: We hypothesized that preferred language mediates the association between race, ethnicity and delays to care. Design Setting And Participants: Multicenter, retrospective cohort study of adults with COVID-19 consecutively admitted...
2.
Martins de Oliveira Filho C, Gavralidis A
Case Rep Hematol . 2022 Dec; 2022:4948115. PMID: 36458103
A 60-year-old female presented with headaches, blurry vision, diplopia, and dizziness for six weeks. Her workup revealed an elevated hematocrit, thrombocytosis, high ferritin, and normal erythropoietin. She was diagnosed with...
3.
Brunner A, Gavralidis A, Al Ali N, Hunter A, Komrokji R, Zeidan A, et al.
Blood Cancer J . 2022 Nov; 12(11):153. PMID: 36379923
Myelodysplastic syndromes (MDS) treated with DNMTI therapy have responses according to the 2006 IWG response criteria. CR responses have had the strongest association with OS. Recently, CR with partial hematologic...
4.
Okin D, Huang C, Alba G, Jesudasen S, Dandawate N, Gavralidis A, et al.
Chest . 2022 Nov; 163(3):533-542. PMID: 36343687
Background: Prone position ventilation (PPV) is resource-intensive, yet the optimal strategy for PPV in intubated patients with COVID-19 is unclear. Research Question: Does a prolonged (24 or more h) PPV...
5.
Moin E, Okin D, Jesudasen S, Dandawate N, Gavralidis A, Chang L, et al.
Resusc Plus . 2022 Mar; 10:100219. PMID: 35284847
Purpose: Code status orders impact clinical outcomes as well as patients' and surrogates' experiences. This is the first multicenter cohort examining code status orders of ICU patients with COVID-19 reported...
6.
Swoboda D, Kanagal-Shamanna R, Brunner A, Cluzeau T, Chan O, Al Ali N, et al.
Leukemia . 2022 Jan; 36(4):1189-1192. PMID: 34975158
No abstract available.
7.
Naranbhai V, Pernat C, Gavralidis A, Denis K, Lam E, Spring L, et al.
J Clin Oncol . 2021 Nov; 40(1):12-23. PMID: 34752147
Purpose: The immunogenicity and reactogenicity of SARS-CoV-2 vaccines in patients with cancer are poorly understood. Methods: We performed a prospective cohort study of adults with solid-organ or hematologic cancers to...
8.
Gavralidis A, Gainor J
Cancer J . 2020 Dec; 26(6):517-524. PMID: 33298723
Non-small cell lung cancer (NSCLC) is a heterogeneous disease, commonly defined by genetic alterations in oncogenic drivers. Targeted therapies have transformed the management of oncogene-driven lung cancers, with targeted agents...
9.
Piper-Vallillo A, Mooradian M, Meador C, Yeap B, Peterson J, Sakhi M, et al.
JTO Clin Res Rep . 2020 Nov; 2(1):100124. PMID: 33205053
Introduction: Lung cancer is associated with severe coronavirus disease 2019 (COVID-19) infections. Symptom overlap between COVID-19 and lung cancer may complicate diagnostic evaluation. We aimed to investigate the incidence, symptoms,...
10.
Gavralidis A, Brunner A
Curr Hematol Malig Rep . 2020 May; 15(4):294-304. PMID: 32445026
Purpose Of Review: Acute lymphoblastic leukemia (ALL) is a rare hematologic malignancy. Advances in multi-agent chemotherapy have resulted in dramatic improvements in the number of pediatric cases that result in...